Ortin Laboratories Financial Statements
Quarterly
Yearly
| Particulars | Dec '20 | Mar '21 | Jun '21 | Sep '21 | Dec '21 |
|---|---|---|---|---|---|
| Revenue | 51.77 | 1.76 | 1.98 | 2.29 | 1.66 |
| Expenses | 50.14 | 1.62 | 1.69 | 2.07 | 1.57 |
| EBITDA | 1.63 | 0.14 | 0.29 | 0.22 | 0.09 |
| EBIT | 1.10 | 0.07 | 0.22 | 0.15 | 0.09 |
| Profit Before Tax | 0.89 | 0.01 | 0.12 | 0.07 | -0.11 |
| Net Profit | 0.60 | 0.80 | 0.09 | 0.05 | -0.09 |
| Financial Ratios | |||||
| Operating Profit Margin | 3.15% | 7.95% | 15.15% | 9.61% | 4.82% |
| Net Profit Margin | 1.16% | 45.45% | 4.55% | 2.18% | -5.42% |
| Earning Per Share (Diluted) | 0.73 | 0.99 | 0.11 | 0.07 | -0.11 |
| Dividends Per Share | NA | NA | NA | NA | NA |
